Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Objectives To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. Design Systematic review and meta-analysis of randomised and observational studies. Data sources Medline, Em...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ
Glavni autori: Li, Ling, Li, Sheyu, Deng, Ke, Liu, Jiali, Vandvik, Per Olav, Zhao, Pujing, Zhang, Longhao, Shen, Jiantong, Bala, Malgorzata M, Sohani, Zahra N, Wong, Evelyn, Busse, Jason W, Ebrahim, Shanil, Malaga, German, Rios, Lorena P, Wang, Yingqiang, Chen, Qunfei, Guyatt, Gordon H, Sun, Xin
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group Ltd. 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772781/
https://ncbi.nlm.nih.gov/pubmed/26888822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.i610
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items